Director share purchases

LungLife AI, INC

14 August 2023

 

 

LungLife AI, Inc.
(the "Company" or "LungLife")

Director share purchases

LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for the early detection of lung cancer, announces that it has received notification of the following transactions in the Company's common shares of US $0.0001 each ("Common Shares") undertaken by directors.

On 14 August 2023, Paul Pagano, Chief Executive Officer, purchased 7,123 Common Shares at a price of 69.84 pence per share. Following this purchase, Paul Pagano now holds 12,123 Common Shares, representing approximately 0.047% of the outstanding share capital of the Company.

In addition, on 14 August 2023, David Anderson, Chief Financial Officer, purchased 7,123 Common Shares at a price of 69.84 pence per share. Following this purchase, David Anderson now holds 12,123 Common Shares, representing approximately 0.047% of the outstanding share capital of the Company.

For further information please contact:

LungLife AI, Inc.	www.lunglifeai.com
Paul Pagano, CEO	Via Walbrook PR
David Anderson, CFO
Investec Bank plc (Nominated Adviser & Joint Broker)	Tel: [phone]
Virginia Bull / Cameron MacRitchie / Lydia Zychowska
Goodbody (Joint Broker) Tom Nicholson / Stephen Kane	Tel: [phone]
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus / Alice Woodings / Phillip Marriage	Mob: [phone]

About LungLife

LungLife AI is a developer of clinical diagnostic solutions designed to make a significant impact in the early detection of lung cancer, the deadliest cancer globally. Using a minimally invasive blood draw, the Company's LungLB® test is designed to deliver additional information to clinicians who are evaluating indeterminate lung nodules. For more information visit www.lunglifeai.com

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them.

1.	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Paul Pagano
2.	Reason for the Notification
a)	Position/status	Chief Executive Officer
b)	Initial notification/amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	LungLife AI, Inc
b)	LEI	549300VBVDIF0Y3OVI38
4.	Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted
a)	Description of the Financial instrument, type of instrument, identification code	Common shares of $0.0001 each in the capital of the Company ISIN: USU5500L1045
b)	Nature of the Transaction	Purchase of Common Shares
c)	Price(s) and volume(s)	Price Volume 69.84 pence 12,123
d)	Aggregated information -     Aggregated volume -     Price	As above
e)	Date of the transaction	14/08/23
f)	Place of the transaction	London Stock Exchange

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them.

1.	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	David Anderson
2.	Reason for the Notification
a)	Position/status	Chief Financial Officer
b)	Initial notification/amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	LungLife AI, Inc
b)	LEI	549300VBVDIF0Y3OVI38
4.	Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted
a)	Description of the Financial instrument, type of instrument, identification code	Common shares of $0.0001 each in the capital of the Company ISIN: USU5500L1045
b)	Nature of the Transaction	Purchase of Common Shares
c)	Price(s) and volume(s)	Price Volume 69.84 pence 12,123
d)	Aggregated information -     Aggregated volume -     Price	As above
e)	Date of the transaction	14/08/23
f)	Place of the transaction	London Stock Exchange

 

END